Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Article
|
Long-term macrolide treatment for chronic respiratory diseaseThe European respiratory journal, 2013-07, Vol.42 (1), p.239-251 [Peer Reviewed Journal]2014 INIST-CNRS ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/09031936.00136712 ;PMID: 23180583Full text available |
|
22 |
Material Type: Article
|
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphomaAnnals of oncology, 2015-08, Vol.26 (8), p.1766-1771 [Peer Reviewed Journal]2015 European Society for Medical Oncology ;The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdv237 ;PMID: 26105599Full text available |
|
23 |
Material Type: Article
|
Trial of Pimavanserin in Dementia-Related PsychosisThe New England journal of medicine, 2021-07, Vol.385 (4), p.309-319 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;Copyright ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034634 ;PMID: 34289275Full text available |
|
24 |
Material Type: Article
|
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trialThe lancet oncology, 2016-07, Vol.17 (7), p.976-983 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 01, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30053-5 ;PMID: 27267608 ;CODEN: LANCAOFull text available |
|
25 |
Material Type: Article
|
Expert consensus document on β-adrenergic receptor blockersEuropean heart journal, 2004-08, Vol.25 (15), p.1341-1362 [Peer Reviewed Journal]ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1016/j.ehj.2004.06.002 ;PMID: 15288162Full text available |
|
26 |
Material Type: Article
|
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid TumorsJournal of clinical oncology, 2017-06, Vol.35 (18), p.2028-2036 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.70.1508 ;PMID: 28463630Full text available |
|
27 |
Material Type: Article
|
Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cellsNature cell biology, 2018-08, Vol.20 (8), p.954-965 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Aug 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1465-7392 ;EISSN: 1476-4679 ;DOI: 10.1038/s41556-018-0140-1 ;PMID: 30022119Full text available |
|
28 |
Material Type: Article
|
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disordersEpilepsia (Copenhagen), 2014-06, Vol.55 (6), p.791-802 [Peer Reviewed Journal]Wiley Periodicals, Inc. © 2014 International League Against Epilepsy ;Wiley Periodicals, Inc. © 2014 International League Against Epilepsy. ;Copyright © 2014 International League Against Epilepsy ;ISSN: 0013-9580 ;EISSN: 1528-1167 ;DOI: 10.1111/epi.12631 ;PMID: 24854329 ;CODEN: EPILAKFull text available |
|
29 |
Material Type: Article
|
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300Annals of oncology, 2018-10, Vol.29 (10), p.2052-2060 [Peer Reviewed Journal]2018 THE AUTHORS ;The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2018 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdy264 ;PMID: 30052729Full text available |
|
30 |
Material Type: Article
|
A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19Antimicrobial agents and chemotherapy, 2020-08, Vol.64 (9) [Peer Reviewed Journal]Copyright © 2020 American Society for Microbiology. ;Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.01061-20 ;PMID: 32661006Full text available |
|
31 |
Material Type: Article
|
Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseasesAnnals of the Rheumatic Diseases, 2020-11, Vol.79 (11), p.1393-1399 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.bmj.com/company/legal-information ;This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2020-217984 ;PMID: 32769150Digital Resources/Online E-Resources |
|
32 |
Material Type: Article
|
First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the IndicationThe New England journal of medicine, 2017-10, Vol.377 (15), p.1409-1412 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1709968 ;PMID: 29020592Full text available |
|
33 |
Material Type: Article
|
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic CorrelatesJournal of clinical oncology, 2010-07, Vol.28 (19), p.3167-3175 [Peer Reviewed Journal]2015 INIST-CNRS ;2010 by American Society of Clinical Oncology 2010 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2009.26.7609 ;PMID: 20516446Full text available |
|
34 |
Material Type: Article
|
Therapeutic Microbiology: The Role of Bifidobacterium breve as Food Supplement for the Prevention/Treatment of Paediatric DiseasesNutrients, 2018-11, Vol.10 (11), p.1723 [Peer Reviewed Journal]2018 by the authors. 2018 ;ISSN: 2072-6643 ;EISSN: 2072-6643 ;DOI: 10.3390/nu10111723 ;PMID: 30423810Full text available |
|
35 |
Material Type: Article
|
Clinical Uses of Melatonin: Evaluation of Human TrialsCurrent medicinal chemistry, 2010-07, Vol.17 (19), p.2070-2095 [Peer Reviewed Journal]2015 INIST-CNRS ;ISSN: 0929-8673 ;EISSN: 1875-533X ;DOI: 10.2174/092986710791233689 ;PMID: 20423309Full text available |
|
36 |
Material Type: Article
|
Targeted therapy in patients with PIK3CA-related overgrowth syndromeNature (London), 2018-06, Vol.558 (7711), p.540-546 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Jun 28, 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-018-0217-9 ;PMID: 29899452Full text available |
|
37 |
Material Type: Article
|
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patientsEMBO molecular medicine, 2014-10, Vol.6 (10), p.1279-1293 [Peer Reviewed Journal]2014 The Authors. Published under the terms of the CC BY 4.0 license ;2014 The Authors. Published under the terms of the CC BY 4.0 license. ;COPYRIGHT 2014 John Wiley & Sons, Inc. ;2014. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 The Authors. Published under the terms of the CC BY 4.0 license 2014 ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201404208 ;PMID: 25214461Full text available |
|
38 |
Material Type: Article
|
Diagnosis and Management of Red Eye in Primary CareAmerican family physician, 2010-01, Vol.81 (2), p.137-144 [Peer Reviewed Journal]American Family Physician ;Copyright American Academy of Family Physicians Jan 15, 2010 ;Copyright American Academy of Family Physicians Dec 15, 2010 ;ISSN: 0002-838X ;EISSN: 1532-0650 ;PMID: 20082509 ;CODEN: AFPYBFFull text available |
|
39 |
Material Type: Article
|
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-ReviewClinical drug investigation, 2018-08, Vol.38 (8), p.653-671 [Peer Reviewed Journal]Springer International Publishing AG, part of Springer Nature 2018 ;Copyright Springer Science & Business Media Aug 2018 ;ISSN: 1173-2563 ;EISSN: 1179-1918 ;DOI: 10.1007/s40261-018-0656-y ;PMID: 29737455Full text available |
|
40 |
Material Type: Article
|
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)British journal of cancer, 2017-06, Vol.117 (1), p.33-40 [Peer Reviewed Journal]Copyright Nature Publishing Group Jun 27, 2017 ;Copyright © 2017 Cancer Research UK 2017 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2017.145 ;PMID: 28588322Full text available |